|
EP1256337A1
|
|
Method and compositions for applying an agent to a substrate
|
|
EP1249231A1
|
|
Pharmaceutical formulations comprising anti-inflammatory compounds and use thereof
|
|
EP1249230A1
|
|
Microemulsion-preconcentrates and microemulsions comprising coenzyme Q10
|
|
AU7638300A
|
|
Microemulsion preconcentrates and microemulsions
|
|
WO0015763A1
|
|
Utilization of nanocells in final culture medium products
|
|
EP0956779A1
|
|
Foods containing water-insoluble compounds
|
|
EP0852941A1
|
|
Nanodispersion cosmetic composition
|
|
EP0866689A1
|
|
Cortisone spray for topical administration
|
|
ZA9607815B
|
|
Nanodispersions for the intravenous administration of an aneasthetic agent having lipophilic properties
|
|
AU6708096A
|
|
Propofol nanodispersions
|
|
WO9637192A1
|
|
Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
|
